TER.NASDAQTeradyne, INC

Form 4: Teradyne CEO Sells 554 Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Gregory Stephen Smith, President and CEO of Teradyne, Inc., reported the sale of 554 shares of common stock at $115 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

  • Gregory Stephen Smith, President and CEO of Teradyne, Inc. (TER), reported the sale of 554 shares of common stock.
  • The transaction occurred on September 12, 2025, with shares sold at a price of $115 each.
  • Following this transaction, Mr. Smith beneficially owns 96,438.995 shares of Teradyne common stock.
  • The sale was executed pursuant to a Rule 10b5-1 sales plan adopted on February 4, 2025.

Sentiment

Score: 5

Explanation: The sale of shares by the CEO is a neutral event as it was conducted under a pre-arranged 10b5-1 plan, which mitigates concerns about opportunistic selling based on insider information. The amount sold is also relatively small compared to total holdings.

Positives

  • The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was not based on new material non-public information.

Negatives

  • Insider selling, even if planned, can sometimes be perceived as a lack of confidence by some investors.

Risks

  • No specific risks are mentioned in this Form 4 filing beyond the general perception of insider selling.

Stakeholder Impact

  • Shareholders: Minor, as the sale was pre-planned and relatively small, reducing the likelihood of negative market reaction.

Key Dates

DateDescription
2025-02-04Date Rule 10b5-1 sales plan was adopted by Gregory Stephen Smith.
2025-09-12Date of transaction where 554 shares of common stock were sold.
2025-09-16Date the Form 4 filing was signed.

Recommendation

hold

This Form 4 filing reports a routine, pre-planned insider stock sale by the CEO. Such transactions, especially when executed under a 10b5-1 plan, are generally not considered indicative of a significant change in company fundamentals or management's long-term outlook. Therefore, it does not provide a basis for a change in investment recommendation.

Keywords

Teradyne, TER, Gregory Stephen Smith, CEO, insider trading, Form 4, stock sale, 10b5-1 plan, common stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.